Dr. Daniel E. Gonzalez, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 249
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: University of Texas Medical Branch at Galveston
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
AR license E-17005 · TX license BP20077394 -
Internal Medicine Physician
TX license BP10064590
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Medical Center-Little Rock Little Rock, AR
Medical groups
- Rheumatology PArtners PLLC (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 249
- Services billed
- 2,855
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 45-59 minutes | 92 | 92 |
| Established patient office or other outpatient visit, 30-39 minutes | 26 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in Little Rock, AR | 240 |
| Prednisone Other prescribers in Little Rock, AR | 234 |
| Hydroxychloroquine Sulfate Other prescribers in Little Rock, AR | 195 |
| Sulfasalazine Dr (sulfasalazine) Other prescribers in Little Rock, AR | 117 |
| Leflunomide Other prescribers in Little Rock, AR | 60 |
| Gabapentin Other prescribers in Little Rock, AR | 47 |
| Allopurinol Other prescribers in Little Rock, AR | 46 |
| Folic Acid Other prescribers in Little Rock, AR | 32 |
| Sulfasalazine Other prescribers in Little Rock, AR | 26 |
| Meloxicam Other prescribers in Little Rock, AR | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 200 payments worth $4,520 in total to this clinician.
| Amgen Inc. | $1,159 |
|---|---|
| AbbVie Inc. | $724 |
| UCB, Inc. | $504 |
| Pfizer Inc. | $377 |
| Novartis Pharmaceuticals Corporation | $270 |
| E.r. Squibb & Sons, L.l.c. | $265 |
| AstraZeneca Pharmaceuticals LP | $198 |
| GlaxoSmithKline, LLC. | $180 |
| Food and Beverage | $4,520 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.